Regulation of cytokine and cytokine receptor expression by glucocorticoids

被引:242
作者
Almawi, WY [1 ]
Beyhum, HN [1 ]
Rahme, AA [1 ]
Rieder, MJ [1 ]
机构
[1] UNIV WESTERN ONTARIO, DEPT PHARMACOL & TOXICOL, LONDON, ON, CANADA
关键词
interleukins; transcription factors; gene expression; mRNA; T cells; T-CELL ACTIVATION; TUMOR-NECROSIS-FACTOR; GROWTH-FACTOR-BETA; COLONY-STIMULATING FACTOR; INTERLEUKIN-2; GENE-TRANSCRIPTION; PROTEIN-PROTEIN-INTERACTION; NORMAL HUMAN-LYMPHOCYTES; BLOOD MONONUCLEAR-CELLS; HUMAN LUNG FIBROBLASTS; NITRIC-OXIDE SYNTHASE;
D O I
10.1002/jlb.60.5.563
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Glucocorticoids (GCS) profoundly inhibit several aspects of T cell immunity largely through inhibition of cytokine expression at the transcriptional and posttranscriptional levels, GCS were also reported to act indirectly by inducing transforming growth factor-beta expression, which in turn blocks T cell immunity, In exerting their antiproliferative effects, GCS diffuse into target cells where they bind their cytoplasmic receptor, which in turn translocates to the nucleus where it inhibits transcription of cytokine genes through direct binding to the glucocorticoid response elements (GRE), which are located in the promoter region of cytokine genes or, alternatively, through antagonism of the action of transcription factors required for optimal transcriptional activation, In contrast to their inhibitory effects on cytokine expression, GCS upregulate cytokine receptor expression that correlates with enhanced cytokine effects on target cells, In this review, we summarize the current state of knowledge of the mechanism of action of GCS, including the phenomenon of steroid-induced rebound, which ensues upon GCS withdrawal.
引用
收藏
页码:563 / 572
页数:10
相关论文
共 166 条
  • [1] ADCOCK IM, 1995, J IMMUNOL, V154, P3500
  • [2] NEGATIVE REGULATION BY GLUCOCORTICOIDS THROUGH INTERFERENCE WITH A CAMP RESPONSIVE ENHANCER
    AKERBLOM, IE
    SLATER, EP
    BEATO, M
    BAXTER, JD
    MELLON, PL
    [J]. SCIENCE, 1988, 241 (4863) : 350 - 353
  • [3] Almawi Wassim Y., 1992, Journal of the American Society of Nephrology, V3, P840
  • [4] ALMAWI WY, 1990, PROG LEUC B, V10, P321
  • [5] ALMAWI WY, 1991, J IMMUNOL, V146, P3523
  • [6] ALMAWI WY, 1993, CLIN APPL CYTOKINES, P269
  • [7] ALMAWI WY, 1996, IN PRESS J IMMUNOL
  • [8] AMANO Y, 1993, MOL PHARMACOL, V43, P176
  • [9] THE ROLE OF JUN, FOS AND THE AP-1 COMPLEX IN CELL-PROLIFERATION AND TRANSFORMATION
    ANGEL, P
    KARIN, M
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1072 (2-3) : 129 - 157
  • [10] IN-VITRO DIFFERENTIAL-EFFECTS OF THE ANTIGLUCOCORTICOID RU486 ON THE RELEASE OF LYMPHOKINES FROM MITOGEN-ACTIVATED NORMAL HUMAN-LYMPHOCYTES
    ANTONAKIS, N
    GEORGOULIAS, V
    MARGIORIS, AN
    STOURNARAS, C
    GRAVANIS, A
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1994, 51 (1-2) : 67 - 72